We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Seer Logo

Seer

Seer develops innovative solutions that act as a gateway to the proteome. Their goal is to empower the scientific community with tools to achieve exceptional scienti?c outcomes. They do this by removing the technological barriers that stand between breakthrough ideas and the information that can make them a reality.

Latest Seer Content

Advances in Proteomics & Metabolomics 2024
Online Event

Advances in Proteomics & Metabolomics 2024

On-Demand
Hear about the latest advancements in translational proteomics and metabolomics. From the molecular mechanisms of disease pathology to the latest technological developments in diagnostics and treatment.
Clinical laboratory worker removing and holding a test tube of blood from a rack containing several samples.
Industry Insight

Leveraging Proteomics for Clinical Biomarker Discovery

In this article, Asim Siddiqui explores the emerging ability of proteomics to reveal new biomarkers for disease.
Omid Farokhzad, chair and CEO at Seer.
Industry Insight

Pushing the Boundaries of Biological Discovery in Proteomics

Dr. Omid Farokhzad, chair and CEO at Seer, discusses how to achieve deep, unbiased and scalable analysis of the proteome at speed at ASMS 2024.
A dark blue wave on a light blue background with the webinar title and date written in white.
Webinar

Exposome Insights: Decoding Spaceflight and Aging With Proteomics

On-Demand
Join expert speakers, Dr. Christopher Mason of Weill Cornell Medicine, and Dr. Michael Roberts of Auburn University, for an enlightening discussion on the profound impacts of spaceflight on human biology and the unique molecular signatures of aging influenced by resistance training.
TN webinar seer bio 23rd May 2024
Webinar

Plasma Proteome Profiling for Lung Cancer Biomarker Discovery

On-Demand
In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how the research sheds new light on early-stage lung cancer diagnostics and clinical outcomes and showcase how multiomics approaches are key for characterizing complex diseases.
A mass spectrometer.
Product News

Seer ProteographTM Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies

Study demonstrates identification of protein altering variants for population-scale protein quantitative trait loci (pQTL) studies. Proteograph Product Suite enables scalable deep, unbiased proteomics by mass spectrometry.
Seer logo.
Product News

Seer Launches the Proteograph XT Assay Kit

Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a range of sample types and species with unprecedented resolution and scale.
Probing the Proteome With Engineered Nanoparticles content piece image
Industry Insight

Probing the Proteome With Engineered Nanoparticles

In this interview, Dr. Daniel Hornburg discusses how engineered nanoparticles could help to bridge the gap between proteomics and genomics and transform cancer diagnostics.
Advertisement